Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A
Natalia Barajas Castrellon, Rared Associate Director Medical and Marketing at Novo Nordisk, reposted from Novo Nordisk on LinkedIn:
”New data from Novo Nordisk in hemophilia A, published in NEJM Group, reinforces the strategic direction of the portfolio.
The results highlight the potential of an investigational prophylactic therapy to reduce bleeding episodes across patient segments, including those with inhibitors – while enabling greater treatment individualization, a key driver of next-generation care models.
This builds on well-established progress in hemophilia, where advances in prophylaxis have materially improved quality of life and extended life expectancy toward that of the general population.”
Novo Nordisk shared on LinkedIn about a recent article by Maria Elisa Mancuso et al, published in NEJM, adding:
”Results from Novo Nordisk’s hemophilia research published in NEJM Group highlights the potential of an investigational preventive bleed treatment option to help people living with hemophilia A, with or without inhibitors.
Learn more in the press release.”
Title: Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
Authors: Maria Elisa Mancuso, Anthony K.C. Chan, Chandrakala Shanmukhaiah, Chuhl Joo Lyu, Joanna Zdziarska, Johnny Mahlangu, Lize F.D. van Vulpen, Pratima Chowdary, Renchi Yang, Steven R. Lentz, Tadashi Matsushita, Wan Hui Ong Clausen, Ilgiz Rakhmatullin, Johannes Oldenburg for the FRONTIER2 Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
May 2, 2026, 13:46Adelia Pramesti Zahra: A Cost of Illness Perspective for Hemophilia in Indonesia
-
May 2, 2026, 13:10Targeting FXIa As a Safer Anticoagulant Target Than FXa in LIBREXIA Trial – JTH
-
May 2, 2026, 10:35Alessandra Bosch: First Comprehensive Swiss Haemophilia Registry Report Now Published
-
May 2, 2026, 10:24From Gene Mutation to Clot Risk in Factor V Leiden – ICHCC
-
May 2, 2026, 10:15Omid Seidizadeh: Enhancing Diagnostic Strategies for von Willebrand Disease Worldwide
-
May 2, 2026, 10:09Scott McLean: Fewer Bleeds Do Not Always Mean a Better Life in Bleeding Disorders
-
May 2, 2026, 10:01Islam Arid: A Practical Guide to ECMO in Modern Intensive Care
-
May 2, 2026, 09:54The West Virginia Department of Health Announces the Stroke Smart West Virginia Initiative
-
May 2, 2026, 09:38Kim Gannon: Stroke Is Treatable and Outcomes Are Dramatically Better When We Act Fast